dc.contributor.author
Carracedo, Miguel
dc.contributor.author
Artiach, Gonzalo
dc.contributor.author
Witasp, Anna
dc.contributor.author
Clària i Enrich, Joan
dc.contributor.author
Carlström, Mattias
dc.contributor.author
Laguna Fernández, Andrés
dc.contributor.author
Stenvinkel, Peter
dc.contributor.author
Bäck, Magnus
dc.date.issued
2019-10-25T12:43:58Z
dc.date.issued
2019-12-01T06:10:18Z
dc.date.issued
2019-09-01
dc.date.issued
2019-10-25T12:43:58Z
dc.identifier
https://hdl.handle.net/2445/143199
dc.description.abstract
AIMS: Vascular calcification, a marker of increased cardiovascular risk, is an active process orchestrated by smooth muscle cells. Observational studies indicate that omega-3 fatty acids protect against vascular calcification, but the mechanisms are unknown. The G-protein coupled receptor ChemR23 transduces the resolution of inflammation induced by the omega-3-derived lipid mediator resolvin E1. ChemR23 also contributes to osteoblastic differentiation of stem cells and bone formation, but its role in vascular calcification is unknown. The aim of this study was to establish the role of ChemR23 in smooth muscle cell fate and calcification. METHODS AND RESULTS: Gene expression analysis in epigastric arteries derived from patients with chronic kidney disease and vascular calcification revealed that ChemR23 mRNA levels predicted a synthetic smooth muscle cell phenotype. Genetic deletion of ChemR23 in mice prevented smooth muscle cell de-differentiation. ChemR23-deficient smooth muscle cells maintained a non-synthetic phenotype and exhibited resistance to phosphate-induced calcification. Moreover, ChemR23-deficient mice were protected against vitamin D3-induced vascular calcification. Resolvin E1 inhibited smooth muscle cell calcification through ChemR23. Introduction of the Caenorhabditis elegans Fat1 transgene, leading to an endogenous omega-3 fatty acid synthesis and hence increased substrate for resolvin E1 formation, significantly diminished the differences in phosphate-induced calcification between ChemR23+/+ and ChemR23-/- mice. CONCLUSION: This study identifies ChemR23 as a previously unrecognized determinant of synthetic and osteoblastic smooth muscle cell phenotype, favouring phosphate-induced vascular calcification. This effect may be of particular importance in the absence of ChemR23 ligands, such as resolvin E1, which acts as a calcification inhibitor under hyperphosphatic conditions.
dc.format
application/pdf
dc.publisher
Oxford University Press
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1093/cvr/cvy316
dc.relation
Cardiovascular Research, 2018, vol. 115, num. 10, p. 1557-1566
dc.relation
https://doi.org/10.1093/cvr/cvy316
dc.rights
(c) European Society of Cardiology, 2018
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Biomedicina)
dc.subject
Proteïnes de membrana
dc.subject
Malalties arterials
dc.subject
Membrane proteins
dc.subject
Arteries Diseases
dc.title
The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion